Sale!

IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the IRF8 gene responsible for rare immune disorders. This comprehensive test utilizes Next Generation Sequencing (NGS) technology to detect autosomal dominant mutations that predispose individuals to mycobacterial infections and immunodeficiency conditions. The test provides crucial information for patients experiencing recurrent infections, unexplained immune deficiencies, or family histories of mycobacteriosis. Results help guide personalized treatment strategies and inform family planning decisions. Available for $500 USD, this test represents a significant advancement in genetic diagnostics for immune system disorders affecting dermatology, osteology, and immunology specialties.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant NGS Genetic DNA Test

Comprehensive Genetic Testing for Immune System Disorders

The IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for rare immune disorders. This advanced test specifically targets mutations in the IRF8 (Interferon Regulatory Factor 8) gene, which plays a critical role in immune system regulation and defense against mycobacterial infections.

What Does This Test Measure?

This sophisticated genetic analysis utilizes Next Generation Sequencing (NGS) technology to comprehensively examine the IRF8 gene for mutations associated with Immunodeficiency Type 32A. The test specifically detects:

  • Autosomal dominant mutations in the IRF8 gene
  • Genetic variants linked to mycobacteriosis susceptibility
  • Mutations affecting immune cell development and function
  • Genetic markers for increased infection risk
  • Inheritance patterns for family planning considerations

Who Should Consider This Test?

This genetic test is particularly recommended for individuals experiencing:

  • Recurrent or severe mycobacterial infections
  • Unexplained immune deficiencies
  • Family history of Immunodeficiency Type 32A
  • Persistent dermatological conditions with immune involvement
  • Osteological manifestations with immune system connections
  • Multiple family members affected by similar immune disorders
  • Children with unusual susceptibility to infections

Clinical Benefits of Genetic Testing

Undergoing the IRF8 Gene Immunodeficiency Type 32A test provides numerous clinical advantages:

  • Early Diagnosis: Enables prompt identification of genetic predisposition to immune disorders
  • Personalized Treatment: Guides targeted therapeutic approaches based on genetic findings
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Preventive Care: Allows for proactive monitoring and preventive measures
  • Comprehensive Understanding: Offers insights into the underlying mechanisms of immune dysfunction

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert genetic counselors and immunology specialists. Results typically fall into three categories:

  • Positive Result: Indicates the presence of IRF8 gene mutations associated with Immunodeficiency Type 32A. This finding enables targeted treatment planning and family screening.
  • Negative Result: Suggests no detectable mutations in the tested regions of the IRF8 gene, though other genetic factors may still contribute to immune issues.
  • Variant of Uncertain Significance: Some genetic changes may require additional research and family studies to determine clinical significance.

Test Information and Pricing

Test Component Details
Test Name IRF8 Gene Immunodeficiency Type 32A Mycobacteriosis Autosomal Dominant NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Specialty Dermatology, Genetics, Immunology
Method NGS Technology

Pre-Test Requirements

Before undergoing testing, patients should provide:

  • Complete clinical history related to immune disorders
  • Genetic counseling session to create family pedigree chart
  • Documentation of affected family members
  • Previous medical records and test results

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic testing facilities ensures accessible, reliable service nationwide.

Take Control of Your Genetic Health

Don’t let uncertainty about your immune health continue. The IRF8 Gene Immunodeficiency Type 32A test provides definitive answers and empowers you with knowledge for better health management. Our team of genetic specialists, dermatologists, and immunology experts are ready to support you through every step of the testing process.

Ready to schedule your genetic test? Contact us today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic predisposition to immune disorders and receive personalized care from America’s leading genetic diagnostics provider.